T. Nii-Kono

Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone.

K. Kurokawa, M. Fukagawa, H. Yamato, 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Intravenous Calcitriol Therapy Increases Serum Concentrations of Fibroblast Growth Factor-23 in Dialysis Patients with Secondary Hyperparathyroidism

S. Fukumoto, M. Fukagawa, H. Nishi, 2005, Nephron Clinical Practice.

Sevelamer Hydrochloride and Calcium Bicarbonate Reduce Serum Fibroblast Growth Factor 23 Levels in Dialysis Patients

T. Shigematsu, M. Fukagawa, J. Kazama, 2005, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells.

K. Kurokawa, M. Fukagawa, H. Yamato, 2007, Kidney international.

Role of fibroblast growth factor 23 in health and in chronic kidney disease

M. Fukagawa, J. Kazama, T. Nii-Kono, 2005, Current opinion in nephrology and hypertension.

Overexpression of thioredoxin1 in transgenic mice suppresses development of diabetic nephropathy.

R. Kitazawa, S. Kitazawa, M. Kasuga, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Overexpression of thioredoxin1 in transgenic mice suppresses development of diabetic nephropathy.

R. Kitazawa, S. Kitazawa, M. Kasuga, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Uremic toxin and bone metabolism

M. Fukagawa, H. Yamato, M. Uchida, 2005, Journal of Bone and Mineral Metabolism.

Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.

T. Shigematsu, F. Gejyo, S. Fukumoto, 2005, Kidney international.

Serum Pro‐hepcidin as an Indicator of Iron Status in Dialysis Patients

T. Abe, H. Fujii, M. Fukagawa, 2008, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Direct Injection of Calcitriol or Its Analog Improves Abnormal Gene Expression in the Hyperplastic Parathyroid Gland in Uremia

I. Hatamura, F. Saji, T. Shigematsu, 2007, American Journal of Nephrology.

Insufficiency of PTH action on bone in uremia.

M. Fukagawa, H. Yamato, M. Uchida, 2006, Kidney international. Supplement.

Administration of oral charcoal adsorbent (AST-120) suppresses low-turnover bone progression in uraemic rats.

M. Fukagawa, H. Yamato, M. Uchida, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.